PLA2R1 and diabetes mellitus: Aside from these considerations, with the important exception of patients with PLA2R antibodies, absence of secondary causes, no diabetes, and eGFR >60 ml/min, renal biopsy might still assist in guiding treatment decisions and provide valuable prognostic insights.